Found: 27
Select item for more details and to access through your institution.
No relation between docetaxel administration route and high‐grade diarrhea incidence.
- Published in:
- Pharmacology Research & Perspectives, 2020, v. 8, n. 4, p. 1, doi. 10.1002/prp2.633
- By:
- Publication type:
- Article
A Phase 1 Dose‐Escalation Study of Low‐Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid Tumors.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 607, doi. 10.1002/cpdd.880
- By:
- Publication type:
- Article
Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours.
- Published in:
- Drugs in R&D, 2021, v. 21, n. 1, p. 103, doi. 10.1007/s40268-020-00336-x
- By:
- Publication type:
- Article
Phase I pharmacological study of continuous chronomodulated capecitabine treatment.
- Published in:
- Pharmaceutical Research, 2020, v. 37, n. 5, p. 1, doi. 10.1007/s11095-020-02828-6
- By:
- Publication type:
- Article
Quantification of the pharmacokinetic-toxicodynamic relationship of oral docetaxel co-administered with ritonavir.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1526, doi. 10.1007/s10637-020-00935-0
- By:
- Publication type:
- Article
Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1).
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 1117, doi. 10.1007/s10637-019-00856-7
- By:
- Publication type:
- Article
Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2).
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 1096, doi. 10.1007/s10637-019-00857-6
- By:
- Publication type:
- Article
'Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183'.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 6, p. 1083, doi. 10.1007/s10637-014-0143-0
- By:
- Publication type:
- Article
Population Pharmacokinetics of Intracellular 5-Fluorouridine 5′-Triphosphate and its Relationship with Hand-and-Foot Syndrome in Patients Treated with Capecitabine.
- Published in:
- AAPS Journal, 2021, v. 23, n. 1, p. 1, doi. 10.1208/s12248-020-00533-1
- By:
- Publication type:
- Article
The effect of Echinacea purpurea on the pharmacokinetics of docetaxel.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 3, p. 467, doi. 10.1111/bcp.12159
- By:
- Publication type:
- Article
Pharmacokinetics of eribulin mesylate in patients with solid tumours receiving repeated oral rifampicin.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 2, p. 507, doi. 10.1111/j.1365-2125.2012.04381.x
- By:
- Publication type:
- Article
Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1125, doi. 10.1007/s10637-013-9923-1
- By:
- Publication type:
- Article
Erratum to: Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I Trials.
- Published in:
- Clinical Pharmacology, 2021, v. 13, p. 21, doi. 10.2147/CPAA.S292746
- By:
- Publication type:
- Article
Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane.
- Published in:
- Journal of Cellular & Molecular Medicine, 2015, v. 19, n. 6, p. 1410, doi. 10.1111/jcmm.12528
- By:
- Publication type:
- Article
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term safety and anti-tumour activity of olaparib monotherapy after combination with carboplatin and paclitaxel in patients with advanced breast, ovarian or fallopian tube cancer.
- Published in:
- British Journal of Cancer, 2015, v. 113, n. 3, p. 396, doi. 10.1038/bjc.2015.256
- By:
- Publication type:
- Article
Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Disposition and metabolism of C-dovitinib (TKI258), an inhibitor of FGFR and VEGFR, after oral administration in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 5, p. 653, doi. 10.1007/s00280-012-1947-2
- By:
- Publication type:
- Article
The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylate.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 6, p. 855, doi. 10.1007/s00280-006-0334-2
- By:
- Publication type:
- Article
The Effect of St John's Wort on the Pharmacokinetics of Docetaxel.
- Published in:
- Clinical Pharmacokinetics, 2014, v. 53, n. 1, p. 103, doi. 10.1007/s40262-013-0102-5
- By:
- Publication type:
- Article
A Phase I dose‐escalation study of two cycles carboplatin‐olaparib followed by olaparib monotherapy in patients with advanced cancer.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 12, p. 3041, doi. 10.1002/ijc.33498
- By:
- Publication type:
- Article
The Use of Dried Blood Spots for Pharmacokinetic Monitoring of Vemurafenib Treatment in Melanoma Patients.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 10, p. 1307, doi. 10.1002/jcph.728
- By:
- Publication type:
- Article
A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. 290, doi. 10.1002/onco.13631
- By:
- Publication type:
- Article
Concise Review: Clinical Relevance of Drug-Drug and Herb-Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein).
- Published in:
- Oncologist, 2007, v. 12, n. 8, p. 927, doi. 10.1634/theoncologist.12-8-927
- By:
- Publication type:
- Article